Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]

Bosani M, Ardizzone S, Porro GB. Biologics: Targets and Therapy. 2009;3:77–97.This paper has been retracted after we were made aware that it contains a large amount of reused, and uncited material that was not placed within quotation marks.The following statement has been supplied by Dr S...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bosani M, Ardizzone S, Porro GB
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/1483e279d73b4d2dbeb521ac0c4d794a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1483e279d73b4d2dbeb521ac0c4d794a
record_format	dspace
spelling	oai:doaj.org-article:1483e279d73b4d2dbeb521ac0c4d794a2021-12-02T07:12:35ZBiologic targeting in the treatment of inflammatory bowel diseases [Retraction]1177-5475https://doaj.org/article/1483e279d73b4d2dbeb521ac0c4d794a2014-01-01T00:00:00Zhttp://www.dovepress.com/retraction-biologic-targeting-in-the-treatment-of-inflammatory-bo-a15660https://doaj.org/toc/1177-5475 Bosani M, Ardizzone S, Porro GB. Biologics: Targets and Therapy. 2009;3:77–97.This paper has been retracted after we were made aware that it contains a large amount of reused, and uncited material that was not placed within quotation marks.The following statement has been supplied by Dr Sandro Ardizzone:The review entitled "Biologic targeting in the treatment of inflammatory bowel disease" has been commissioned by this journal and published in 2009 (Matteo Bosani, Sandro Ardizzone, Gabriele Bianchi Porro. Biologics: Targets & Therapy 2009;3:77–97). The paper was written by our young coworker (Dr M Bosani). He has consulted many papers, including our previous reviews published years before. The not perfect knowledge of English language has greatly influenced the writing of the paper itself. So he saved in word file several parts of our previous papers (Ardizzone S, Bianchi Porro G. Inflammatory bowel disease: new insights into pathogenesis and treatment. J Intern Med 2002;252:475–496 – Ardizzone S, Bianchi Porro G. Biologic therapy for inflammatory bowel disease. Drugs 2005:2253–2286), and then transferred to the final paper. He was unaware as we are, of the fact that he could not reuse previously published material in other journals. The reuse of this material was made in good faith.Taking our responsibility for what happened, we intend to apologize for this inconvenience to the Editor (Dr Doris Benbrook) and Publisher (Dr Tim Hill). Moreover, for the reasons mentioned above, I consider appropriate to retract the paper itself.This retraction relates to this paper.Bosani MArdizzone SPorro GBDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2014, Iss default, Pp 39-40 (2014)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Bosani M Ardizzone S Porro GB Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
description	Bosani M, Ardizzone S, Porro GB. Biologics: Targets and Therapy. 2009;3:77–97.This paper has been retracted after we were made aware that it contains a large amount of reused, and uncited material that was not placed within quotation marks.The following statement has been supplied by Dr Sandro Ardizzone:The review entitled "Biologic targeting in the treatment of inflammatory bowel disease" has been commissioned by this journal and published in 2009 (Matteo Bosani, Sandro Ardizzone, Gabriele Bianchi Porro. Biologics: Targets & Therapy 2009;3:77–97). The paper was written by our young coworker (Dr M Bosani). He has consulted many papers, including our previous reviews published years before. The not perfect knowledge of English language has greatly influenced the writing of the paper itself. So he saved in word file several parts of our previous papers (Ardizzone S, Bianchi Porro G. Inflammatory bowel disease: new insights into pathogenesis and treatment. J Intern Med 2002;252:475–496 – Ardizzone S, Bianchi Porro G. Biologic therapy for inflammatory bowel disease. Drugs 2005:2253–2286), and then transferred to the final paper. He was unaware as we are, of the fact that he could not reuse previously published material in other journals. The reuse of this material was made in good faith.Taking our responsibility for what happened, we intend to apologize for this inconvenience to the Editor (Dr Doris Benbrook) and Publisher (Dr Tim Hill). Moreover, for the reasons mentioned above, I consider appropriate to retract the paper itself.This retraction relates to this paper.
format	article
author	Bosani M Ardizzone S Porro GB
author_facet	Bosani M Ardizzone S Porro GB
author_sort	Bosani M
title	Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
title_short	Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
title_full	Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
title_fullStr	Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
title_full_unstemmed	Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
title_sort	biologic targeting in the treatment of inflammatory bowel diseases [retraction]
publisher	Dove Medical Press
publishDate	2014
url	https://doaj.org/article/1483e279d73b4d2dbeb521ac0c4d794a
work_keys_str_mv	AT bosanim biologictargetinginthetreatmentofinflammatoryboweldiseasesretraction AT ardizzones biologictargetinginthetreatmentofinflammatoryboweldiseasesretraction AT porrogb biologictargetinginthetreatmentofinflammatoryboweldiseasesretraction
_version_	1718399557409177600

Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]

Ejemplares similares